Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia.
Curr Pharm Biotechnol. 2016;17(1):6-19. doi: 10.2174/1389201016666150907113653.
Curr Pharm Biotechnol. 2016.
PMID: 26343130
Review.
A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia.
Bjørnstad R, Aesoy R, Bruserud Ø, Brenner AK, Giraud F, Dowling TH, Gausdal G, Moreau P, Døskeland SO, Anizon F, Herfindal L.
Bjørnstad R, et al. Among authors: dowling th.
Mol Cancer Ther. 2019 Mar;18(3):567-578. doi: 10.1158/1535-7163.MCT-17-1234. Epub 2019 Jan 24.
Mol Cancer Ther. 2019.
PMID: 30679386
Item in Clipboard
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia.
Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S.
Caulier B, et al. Among authors: dowling th.
Cell Rep Med. 2024 May 8:101572. doi: 10.1016/j.xcrm.2024.101572. Online ahead of print.
Cell Rep Med. 2024.
PMID: 38754420
Free article.
Item in Clipboard
Cite
Cite